港股異動丨內房股集體上升,中國恒大和碧桂園升超4%
港股市場內房股集體上升,其中,金地商置升7%,中梁控股升超5%,中國恒大、德信中國和碧桂園升超4%,龍湖集團、新城發展升超3%,萬科企業、融創中國、龍光集團升超2%。有媒體稱,昨日下午,人民銀行、住建部、金融監管總局、證監會聯合召集數家房企座談,瞭解行業資金狀況和企業融資需求。據悉,參會企業包括萬科、保利、華潤、中海、龍湖和金地等。另外,民企債券融資支持工具(業內稱“第二支箭”)助力民營房企融資又有新進展。人民銀行積極落實中央金融工作會議指示精神,持續加力推動“第二支箭”支持民營房地產企業債券融資。據悉,近期“第二支箭”將支持新城控股、美的置業、卓越商管等民營房企發行債券融資。同時,龍湖、金輝、華宇、新希望地產等多家民營房企債券發行項目正在穩步推進中。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.